EUVIMEDEUVIMED entdecken
Open Access · CC BY 2.0

Targeting CLK1 by CRISPR tools and pharmacological inhibition modulates the innate immune response and dengue virus replication

Berta Pozzi iD, Agustina Magalí Lucero, Valeria Buggiano, Miguel Angel Pelaez, Cybele Carina García, Anabella Srebrow iD

Biochemical Journal · 02.12.2026 · 483 (12) · 2307-2325

DOI: 10.1042/bcj20260367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Journal, online erschienen am 05.11.2026. Verfasst von Berta Pozzi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Departamento de Fisiología, Biología Molecular y Celular, Buenos Aires, Argent…. Hauptthemen laut MEDLINE: Dengue Virus, Protein Serine-Threonine Kinases, Virus Replication, Immunity, Innate. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: Secretaria de Innovacion, Ciencia y Tecnologia (ex Ministerio de Ciencia, Tecnologia e Innovacion) de Argentina, UBA | Secretaría de Ciencia y Técnica, Universidad de Buenos Aires (UBACyT), Agencia Nacional de Investigaciones Cientificas y Tecnologicas de Argentina.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alternative splicing is a key regulatory mechanism known to be altered upon viral infection. These alterations can arise both from direct viral interference with the splicing machinery and from cellular responses such as activation of innate immunity. Here, we investigated splicing changes shared between dengue virus (DENV) infection and interferon (IFN) treatment in cultured cells, the latter serving as a model for virus-independent innate immune activation. Among the common events, we identified an increased production of non-coding mRNA isoforms from the CLK1 gene, which gives rise to a kinase that phosphorylates splicing factors including SR proteins and spliceosomal components. Consistent with this finding, IFN treatment led to a reduction in CLK1 protein levels. Using stable cell lines with CRISPR/dCas9-mediated modulation of CLK1 expression, we found that silencing CLK1 enhanced the induction of immune response genes, while its overexpression attenuated it. Inhibition of CLK1 kinase activity with the pharmacological inhibitor TG003 further potentiated IFN-induced gene expression and reduced DENV replication. Altogether, these results identify CLK1 as a proviral negative regulator of IFN-stimulated gene expression and suggest that its inhibition could enhance antiviral defenses and become a target for therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dengue VirusProtein Serine-Threonine KinasesVirus ReplicationImmunity, InnateDengueCRISPR-Cas SystemsHumansAnimalsAlternative SplicingInterferonsProtein-Tyrosine Kinases

Stichwörter der Autor:innen

SR protein kinasedengue virusinnate immunityinterferon stimulated genes

Substanzen

Protein Serine-Threonine KinasesClk dual-specificity kinasesInterferonsProtein-Tyrosine Kinases

Autor:innen und Institutionen

  • Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Departamento de Fisiología, Biología Molecular y Celular, Buenos Aires, Argentina.
  • CONICET-Universidad de Buenos Aires, Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE), Buenos Aires, Argentina.
  • Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Departamento de Química Biológica, Buenos Aires, Argentina.
  • CONICET-Universidad de Buenos Aires, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Buenos Aires, Argentina.

ORCID-Profile: Berta Pozzi, Anabella Srebrow

Förderung

  • Secretaria de Innovacion, Ciencia y Tecnologia (ex Ministerio de Ciencia, Tecnologia e Innovacion) de Argentina
  • UBA | Secretaría de Ciencia y Técnica, Universidad de Buenos Aires (UBACyT)
  • Agencia Nacional de Investigaciones Cientificas y Tecnologicas de Argentina

Zitieren

APA

Pozzi, B., Lucero, A. M., Buggiano, V., Pelaez, M. A., García, C. C., & Srebrow, A. (2026). Targeting CLK1 by CRISPR tools and pharmacological inhibition modulates the innate immune response and dengue virus replication. Biochemical Journal, 483(12), 2307-2325. https://doi.org/10.1042/bcj20260367

Vancouver

Pozzi B, Lucero AM, Buggiano V, Pelaez MA, García CC, Srebrow A. Targeting CLK1 by CRISPR tools and pharmacological inhibition modulates the innate immune response and dengue virus replication. Biochemical Journal. 2026;483(12):2307-2325. doi:10.1042/bcj20260367

BibTeX
@article{Pozzi2026,
  author = {Pozzi, Berta and Lucero, Agustina Magalí and Buggiano, Valeria and Pelaez, Miguel Angel and García, Cybele Carina and Srebrow, Anabella},
  title = {Targeting CLK1 by CRISPR tools and pharmacological inhibition modulates the innate immune response and dengue virus replication},
  journal = {Biochemical Journal},
  year = {2026},
  volume = {483},
  number = {12},
  pages = {2307--2325},
  doi = {10.1042/bcj20260367}
}
Kostenlos starten →